Abstract :

Chromosomal mosaicism in preimplantation embryos, characterized by cells with varying genotypes, arises due to mitotic errors after fertilization. These errors, including anaphase lag, mitotic nondisjunction, or cytokinesis failure, typically occur during early embryonic divisions when maternal factors predominantly regulate development. The impact of mosaicism on embryonic viability varies based on the stage and nature of the chromosomal errors, potentially reducing implantation rates and increasing miscarriage risks. However, mosaic embryos can occasionally self-correct through apoptosis of abnormal cells or selective growth of euploid cells, enabling the development of healthy blastocysts.

Advancements in genetic screening, particularly next-generation sequencing (NGS), have improved mosaicism detection, although challenges remain in accurately interpreting its clinical significance. NGS identifies mosaicism with higher sensitivity than previous methods like fluorescence in situ hybridization (FISH) or array comparative genomic hybridization (aCGH). Nonetheless, discrepancies in detection rates and sampling errors complicate clinical decision-making.

Patients undergoing preimplantation genetic testing must be counseled on the potential outcomes of transferring mosaic embryos, especially when euploid options are unavailable. While mosaic embryos offer a chance for pregnancy, they carry an increased risk of miscarriage and uncertain long-term outcomes. Personalized genetic counseling and improved screening methodologies are essential for refining patient care and optimizing in vitro fertilization (IVF) outcomes. Further research is needed to understand the mechanisms and implications of mosaicism, ensuring evidence-based practices in embryo selection and transfer.

---

Keywords :

Chromosomal Mosaicism, In Vitro Fertilization (IVF), Next-Generation Sequencing (NGS)., Preimplantation Embryos, Preimplantation Genetic Screening (PGS)

---

References :

1. Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MH, Winston RM. Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation,(FISH). Human molecular genetics. 1993 Aug 1;2(8):1183-5.
2. Munné S, Weier HU, Grifo J, Cohen J. Chromosome mosaicism in human embryos. Biology of reproduction. 1994 Sep 1;51(3):373-9.
3. Mantikou E, Wong KM, Repping S, Mastenbroek S. Molecular origin of mitotic aneuploidies in preimplantation embryos. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012 Dec 1;1822(12):1921-30.
4. McCoy RC. Mosaicism in preimplantation human embryos: when chromosomal abnormalities are the norm. Trends in genetics. 2017 Jul 1;33(7):448-63.
5. Harzif AK, Andyra AF, Sayogo A, Ummah NA, Puspawardani AR, Nurbaeti P, Wiweko B. Embryo response to aneuploidy through self-correction mechanism: a literature review. Middle East Fertility Society Journal. 2024 Mar 19;29(1):16.
6. Bazrgar M, Gourabi H, Valojerdi MR, Yazdi PE, Baharvand H. Self-correction of chromosomal abnormalities in human preimplantation embryos and embryonic stem cells. Stem cells and development. 2013 Sep 1;22(17):2449-56.
7. Munné S, Velilla E, Colls P, Bermudez MG, Vemuri MC, Steuerwald N, Garrisi J, Cohen J. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertility and sterility. 2005 Nov 1;84(5):1328-34.
8. Viotti M. Preimplantation genetic testing for chromosomal abnormalities: aneuploidy, mosaicism, and structural rearrangements. Genes. 2020 May 29;11(6):602.
9. Sachdev NM, Maxwell SM, Besser AG, Grifo JA. Diagnosis and clinical management of embryonic mosaicism. Fertility and Sterility. 2017 Jan 1;107(1):6-11.
10. Holubcová Z, Blayney M, Elder K, Schuh M. Error-prone chromosome-mediated spindle assembly favors chromosome segregation defects in human oocytes. Science. 2015 Jun 5;348(6239):1143-7.
11. McCoy RC, Newnham LJ, Ottolini CS, Hoffmann ER, Chatzimeletiou K, Cornejo OE, Zhan Q, Zaninovic N, Rosenwaks Z, Petrov DA, Demko ZP. Tripolar chromosome segregation drives the association between maternal genotype at variants spanning PLK4 and aneuploidy in human preimplantation embryos. Human molecular genetics. 2018 Jul 15;27(14):2573-85.
12. Benn P. Uniparental disomy: origin, frequency, and clinical significance. Prenatal diagnosis. 2021 Apr;41(5):564-72.
13. Grati FR. Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. Journal of clinical medicine. 2014 Jul 24;3(3):809-37.
14. Zore T, Kroener LL, Wang C, Liu L, Buyalos R, Hubert G, Shamonki M. Transfer of embryos with segmental mosaicism is associated with a significant reduction in live-birth rate. Fertility and sterility. 2019 Jan 1;111(1):69-76.
15. Sachdev NM, McCulloh DH, Kramer Y, Keefe D, Grifo JA. The reproducibility of trophectoderm biopsies in euploid, aneuploid, and mosaic embryos using independently verified next-generation sequencing (NGS): a pilot study. Journal of Assisted Reproduction and Genetics. 2020 Mar;37:559-71.
16. Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. New England Journal of Medicine. 2015 Nov 19;373(21):2089-90.
17. Spinella F, Fiorentino F, Biricik A, Bono S, Ruberti A, Cotroneo E, Baldi M, Cursio E, Minasi MG, Greco E. Extent of chromosomal mosaicism influences the clinical outcome of in vitro fertilization treatments. Fertility and sterility. 2018 Jan 1;109(1):77-83.
18. Gleicher N, Metzger J, Croft G, Kushnir VA, Albertini DF, Barad DH. A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use. Reproductive Biology and Endocrinology. 2017 Dec;15:1-8.
19. Fragouli E, Alfarawati S, Spath K, Babariya D, Tarozzi N, Borini A, Wells D. Analysis of implantation and ongoing pregnancy rates following the transfer of mosaic diploid–aneuploid blastocysts. Human genetics. 2017 Jul;136(7):805-19.
20. Cram DS, Leigh D, Handyside A, Rechitsky L, Xu K, Harton G, Grifo J, Rubio C, Fragouli E, Kahraman S, Forman E. PGDIS position statement on the transfer of mosaic embryos 2019. Reproductive biomedicine online. 2019 Aug;39:e1-4.
21. Grati FR, Gallazzi G, Branca L, Maggi F, Simoni G, Yaron Y. An evidence-based scoring system for prioritizing mosaic aneuploid embryos following preimplantation genetic screening. Reproductive biomedicine online. 2018 Apr 1;36(4):442-9.
22. Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Molecular human reproduction. 2000 Nov 1;6(11):1055-62.
23. Zhang S, Luo K, Cheng D, Tan Y, Lu C, He H, Gu Y, Lu G, Gong F, Lin G. Number of biopsied trophectoderm cells is likely to affect the implantation potential of blastocysts with poor trophectoderm quality. Fertility and sterility. 2016 May 1;105(5):1222-7.
24. Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences?. Journal of assisted reproduction and genetics. 2016 Jul;33:823-32.
25. Fragouli E, Alfarawati S, Daphnis DD, Goodall NN, Mania A, Griffiths T, Gordon A, Wells D. Cytogenetic analysis of human blastocysts with the use of FISH, CGH and aCGH: scientific data and technical evaluation. Human Reproduction. 2011 Feb 1;26(2):480-90.
26. Mamas T, Gordon A, Brown A, Harper J, SenGupta S. Detection of aneuploidy by array comparative genomic hybridization using cell lines to mimic a mosaic trophectoderm biopsy. Fertility and sterility. 2012 Apr 1;97(4):943-7.
27. Capalbo A, Wright G, Elliott T, Ubaldi FM, Rienzi L, Nagy ZP. FISH reanalysis of inner cell mass and trophectoderm samples of previously array-CGH screened blastocysts shows high accuracy of diagnosis and no major diagnostic impact of mosaicism at the blastocyst stage. Human reproduction. 2013 Aug 1;28(8):2298-307.
28. Wells D, Kaur K, Grifo J, Glassner M, Taylor JC, Fragouli E, Munne S. Clinical utilisation of a rapid low-pass whole genome sequencing technique for the diagnosis of aneuploidy in human embryos prior to implantation. Journal of medical genetics. 2014 Aug 1;51(8):553-62.
29. Garrisi G, Walmsley RH, Bauckman K, Mendola RJ, Colls P, Munne S. Discordance among serial biopsies of mosaic embryos. Fertility and Sterility. 2016 Sep 1;106(3):e151.
30. Maxwell SM, Colls P, Hodes-Wertz B, McCulloh DH, McCaffrey C, Wells D, Munné S, Grifo JA. Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing. Fertility and sterility. 2016 Nov 1;106(6):1414-9.
31. Wilton L, Williamson R, McBain J, Edgar D, Voullaire L. Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization. New England Journal of Medicine. 2001 Nov 22;345(21):1537-41.
32. Daphnis DD, Delhanty JD, Jerkovic S, Geyer J, Craft I, Harper JC. Detailed FISH analysis of day 5 human embryos reveals the mechanisms leading to mosaic aneuploidy. Human Reproduction. 2005 Jan 1;20(1):129-37.
33. Turner K, Fowler K, Fonseka G, Griffin D, Ioannou D. Multicolour detection of every chromosome as a means of detecting mosaicism and nuclear organization in human embryonic nuclei. Panminerva medica. 2016 Mar 16.
34. Sachdev NM, Ribustello L, Liu E, McCulloh DH, Grifo J, Munne S. The rate of mosaic embryos from donor egg as detected by next generation sequencing (NGS) varies by IVF laboratory. Fertility and Sterility. 2016 Sep 1;106(3):e156-7.
35. Munné S, Grifo J, Wells D. Mosaicism: “survival of the fittest” versus “no embryo left behind”. Fertility and sterility. 2016 May 1;105(5):1146-9.
36. Vera-Rodríguez M, Michel CE, Mercader A, Bladon AJ, Rodrigo L, Kokocinski F, Mateu E, Al-Asmar N, Blesa D, Simón C, Rubio C. Distribution patterns of segmental aneuploidies in human blastocysts identified by next-generation sequencing. Fertility and Sterility. 2016 Apr 1;105(4):1047-55.